AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 139 filers reported holding AMICUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $18,350,000 | -28.0% | 3,692,098 | +7.2% | 0.00% | -25.0% |
| Q3 2016 | $25,489,000 | +44.1% | 3,444,510 | +6.3% | 0.00% | +33.3% |
| Q2 2016 | $17,694,000 | -28.5% | 3,240,568 | +10.7% | 0.00% | -25.0% |
| Q1 2016 | $24,737,000 | -14.3% | 2,927,472 | -1.6% | 0.00% | -20.0% |
| Q4 2015 | $28,854,000 | -24.5% | 2,974,625 | +8.8% | 0.01% | -28.6% |
| Q3 2015 | $38,242,000 | +43.4% | 2,733,559 | +45.1% | 0.01% | +75.0% |
| Q2 2015 | $26,664,000 | +114.7% | 1,884,381 | +65.1% | 0.00% | +100.0% |
| Q1 2015 | $12,418,000 | +160.9% | 1,141,356 | +99.5% | 0.00% | +100.0% |
| Q4 2014 | $4,760,000 | +3478.9% | 572,094 | +2466.9% | 0.00% | – |
| Q3 2014 | $133,000 | -76.9% | 22,287 | -92.0% | 0.00% | – |
| Q1 2014 | $575,000 | -11.5% | 277,718 | +0.5% | 0.00% | – |
| Q4 2013 | $650,000 | -11.3% | 276,465 | -12.5% | 0.00% | – |
| Q3 2013 | $733,000 | -8.6% | 315,974 | -8.2% | 0.00% | – |
| Q2 2013 | $802,000 | – | 344,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |